UsingDrosophilamodels of neurodegenerative diseases for drug discovery-Reference-Cited by-同舟云学术

UsingDrosophilamodels of neurodegenerative diseases for drug discovery

Published:2011-01-22 Issue:2 Volume:6 Page:129-140
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Newman Tracey,Sinadinos Christopher,Johnston Alex,Sealey Megan,Mudher Amrit

Publisher

Informa Healthcare

Subject

Drug Discovery

Link

http://www.tandfonline.com/doi/pdf/10.1517/17460441.2011.549124

Reference69 articles.

1. Pharmacological prevention of Parkinson disease in Drosophila

2. Mudher A, Newman TA. Drosophila: a toolbox for the study of neurodegenerative disease. Taylor & Francis, New York, Abingdon; 2008

3. Greenspan RJ. Fly pushing: the theory and practice of Drosophila genetics. 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY; 2004

4. The Drosophila melanogaster circadian pacemaker circuit

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Globodera pallida, a non-transgenic invertebrate as a new model for investigating Alzheimer’s disease (and other proteinopathies)?;Neural Regeneration Research;2023

2. Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer’s Disease;ACS Chemical Neuroscience;2022-11-29

3. Anti-Aging Effects of R-Phycocyanin from Porphyra haitanensis on HUVEC Cells and Drosophila melanogaster;Marine Drugs;2022-07-22

4. Proof-of-Concept Preclinical Use of Drosophila melanogaster in the Initial Screening of Immunomodulators;Scientia Pharmaceutica;2022-02-08

5. Modulation of Huntington’s Disease in Drosophila;CNS & Neurological Disorders - Drug Targets;2021-12-01